Literature DB >> 20208177

Crystallization and preliminary crystallographic studies of the catalytic subunits of human pyruvate dehydrogenase phosphatase isoforms 1 and 2.

Junko Kato1, Masato Kato.   

Abstract

Pyruvate dehydrogenase phosphatase (PDP) is a mitochondrial serine phosphatase that activates phosphorylated pyruvate dehydrogenase complex by dephosphorylation. In humans, two PDP isoforms (1 and 2) have been identified. PDP1 is composed of a catalytic subunit (PDP1c) and a regulatory subunit (PDP1r), whereas PDP2 consists of only a catalytic subunit (PDP2c). Both PDP1c and PDP2c have been crystallized individually and complete X-ray diffraction data sets have been collected to 2.45 and 2.0 A resolution, respectively. The PDP1c crystals belonged to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = b = 65.1, c = 216.1 A. The asymmetric unit is expected to contain one molecule, with a Matthews coefficient V(M) of 2.56 A(3) Da(-1). The PDP2c crystals belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 53.6, b = 69.1, c = 109.7 A. The asymmetric unit is expected to contain one molecule, with a Matthews coefficient V(M) of 1.91 A(3) Da(-1).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208177      PMCID: PMC2833053          DOI: 10.1107/S1744309110003131

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  15 in total

1.  Characterization of the isozymes of pyruvate dehydrogenase phosphatase: implications for the regulation of pyruvate dehydrogenase activity.

Authors:  Tatiana Karpova; Svitlana Danchuk; Elena Kolobova; Kirill M Popov
Journal:  Biochim Biophys Acta       Date:  2003-12-01

Review 2.  Regulation of the activity of the pyruvate dehydrogenase complex.

Authors:  Robert A Harris; Melissa M Bowker-Kinley; Boli Huang; Pengfei Wu
Journal:  Adv Enzyme Regul       Date:  2002

3.  Regulation of mammalian pyruvate and branched-chain alpha-keto acid dehydrogenase complexes by phosphorylation-dephosphorylation.

Authors:  L J Reed; Z Damuni; M L Merryfield
Journal:  Curr Top Cell Regul       Date:  1985

4.  Structural requirements within the lipoyl domain for the Ca2+-dependent binding and activation of pyruvate dehydrogenase phosphatase isoform 1 or its catalytic subunit.

Authors:  Ali Turkan; Xiaoming Gong; Tao Peng; Thomas E Roche
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

5.  Pyruvate dehydrogenase phosphatase from bovine heart.

Authors:  F H Pettit; W M Teague; L J Reed
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues.

Authors:  P Wu; P V Blair; J Sato; J Jaskiewicz; K M Popov; R A Harris
Journal:  Arch Biochem Biophys       Date:  2000-09-01       Impact factor: 4.013

7.  Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype.

Authors:  J M Cameron; M Maj; V Levandovskiy; C P Barnett; S Blaser; N Mackay; J Raiman; A Feigenbaum; A Schulze; B H Robinson
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

8.  Purification and properties of pyruvate dehydrogenase phosphatase from bovine heart and kidney.

Authors:  W M Teague; F H Pettit; T L Wu; S R Silberman; L J Reed
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

9.  Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney.

Authors:  Boli Huang; Pengfei Wu; Kirill M Popov; Robert A Harris
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

Review 10.  Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation.

Authors:  M J Holness; M C Sugden
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  1 in total

Review 1.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.